SAN FRANCISCO – DecisionView, Inc., a leading provider of software solutions to optimize clinical trial enrollment for life sciences companies, is pleased to announce that DecisionView President and COO Linda Drumright will moderate an expert panel discussion on Patient Enrollment at the 46th DIA Annual Meeting (June 13-17, 2010 in Washington, DC.). Ms. Drumright will be joined by industry experts from Pfizer and GlaxoSmithKline, who will share their first-hand experiences in driving the evolution of patient enrollment processes within their organizations.
Patient Enrollment is at the heart of all clinical trials. Yet in many organizations, the systems and tools available for planning and tracking trials are immature, require manual inputs, and lack the features and flexibility clinical planners and trial managers need. The result: 72% of studies are delayed by more than a month, at an average cost of $37,000 per day.
Industry experts from Pfizer, GlaxoSmithKline and DecisionView will share their first-hand experiences in evolving patient enrollment processes to foster collaboration and data-driven decision-making through an enrollment “planning culture”. During the session, panelists will address some of the most challenging enrollment performance issues faced by the industry today, including:
In addition, the session will include expert presentations by each of the panelists, including:
